Slingshot members are tracking this event:
Agios (AGIO) to Present Data on Expansion Phase 1 Study of AG-120 in Advanced 1DH1 Mutant Positive Low-Grade Glioma in the Second Half of 2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Nov 18, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Expansion Phase, Phase 1, Ag-120, Advanced Idh1 Mutant Positive Low-grade, Glioma, Data Release